Pediatrix Medical Group, Inc. (MD) has a MoatMap StockRank of 98/100 based on Quality (62/100), Value (63/100), and Momentum (70/100) factor scores. The current signal is STRONG BUY. Pediatrix Medical Group is a healthcare services provider facing persistent labor cost pressures and reimbursement challenges, with no clear connection to our core macro themes.
Pediatrix Medical Group, Inc. is a leading provider of physician services specializing in neonatology, anesthesiology, and maternal-fetal medicine to hospitals and patients throughout the United States. The company's strength lies in its extensive network of highly specialized clinicians and deep clinical expertise in critical care for women and children. This focused service offering and integrated practice management capabilities establish it as a key partner in healthcare delivery.
| Price | $23.66 |
| Market Cap | $1.8B |
| P/E (TTM) | 10.86 |
| P/E (Forward) | 9.48 |
| Price/Book | 2.04 |
| Return on Equity | 20.9% |
| Return on Invested Capital | 14.1% |
| Debt/Equity | 71.67 |
| Gross Margin | 26.1% |
| Operating Margin | 9.8% |
| Revenue Growth | 3.9% |
| Free Cash Flow | $164M |
Pediatrix Medical Group, Inc. operates in the Medical Care Facilities industry, part of the Healthcare sector (United States).